Literature DB >> 8033341

Rat dilated cardiomyopathy after autoimmune giant cell myocarditis.

M Kodama1, H Hanawa, M Saeki, H Hosono, T Inomata, K Suzuki, A Shibata.   

Abstract

One of the possible causes of dilated cardiomyopathy is considered to be a sequel to myocarditis. Two mechanisms have been proposed in the process of progression of myocarditis into dilated cardiomyopathy: one is a persistent viral infection, and the other is an autoimmune myocardial injury. To clarify the possible part played by the autoimmune mechanism in the process, using an animal model, we investigated whether autoimmune myocarditis, exclusively not related to viral infection, might develop into dilated cardiomyopathy. Experimental autoimmune myocarditis was elicited in Lewis rats by immunization with cardiac myosin fraction. Rats of the control group were immunized with ovalbumin. The clinical course was observed over 4 months. Six rats from the myosin-immunized group died during the acute phase and the healing phase, and all those rats had severe myocarditis. All rats that survived until the end of the study showed enlarged and discolored hearts. Aneurysmal changes were observed in the right ventricle during thoracotomy. The ratio of heart weight to body weight of the myosin-immunized group was significantly higher than that of the control group (3.36 +/- 0.49 versus 2.69 +/- 0.06 g/kg, respectively; P < .005). The lengths of the anterior interventricular fissure and the posterior interventricular fissure of the hearts of the myosin-immunized group were significantly longer than those of the control group. The external diameter of the left ventricle of the myosin-immunized group was also significantly larger than that of the control group. Diffuse myocardial muscle loss and replacement fibrosis were the prominent histological findings of the rats of the myosin-immunized group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033341     DOI: 10.1161/01.res.75.2.278

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  A novel phenylpyridazinone, T-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy.

Authors:  Fadia Ali Kamal; Kenichi Watanabe; Meilei Ma; Yuichi Abe; Reyad Elbarbary; Makoto Kodama; Yoshifusa Aizawa
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

2.  Myosin-induced autoimmune myocarditis in BALB/C mice.

Authors:  Z Wang; Y Liao; J Dong; S Li; J Wang; Y Tu
Journal:  J Tongji Med Univ       Date:  1999

3.  Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.

Authors:  Shouxin Zhang; Xiaoyan Liu; Chengming Sun; Jun Yang; Lihong Wang; Jie Liu; Lei Gong; Yanyan Jing
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

4.  Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis.

Authors:  K Fuse; M Kodama; H Hanawa; Y Okura; M Ito; T Shiono; S Maruyama; S Hirono; K Kato; K Watanabe; Y Aizawa
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

5.  Effects of hepatocyte growth factor in myocarditis rats induced by immunization with porcine cardiac myosin.

Authors:  Jota Nakano; Akira Marui; Hiroyuki Muranaka; Hidetoshi Masumoto; Hisashi Noma; Yasuhiko Tabata; Akio Ido; Hirohito Tsubouchi; Tadashi Ikeda; Ryuzo Sakata
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-09

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  FR167653 suppresses the progression of experimental autoimmune myocarditis.

Authors:  Seitaro Maruyama; Kiminori Kato; Makoto Kodama; Yuji Okura; Satoru Hirono; Koichi Fuse; Haruo Hanawa; Osamu Nakagawa; Mikio Nakazawa; Takashi Miida; Eisin Yaoita; Tadashi Yamamoto; Ikuo Inoue; Yoshifusa Aizawa
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

8.  Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.

Authors:  Adita Mascaro-Blanco; Kathy Alvarez; Xichun Yu; JoAnn Lindenfeld; Leann Olansky; Timothy Lyons; David Duvall; Janet S Heuser; Albina Gosmanova; Carl J Rubenstein; Leslie T Cooper; David C Kem; Madeleine W Cunningham
Journal:  Autoimmunity       Date:  2008-09       Impact factor: 2.815

Review 9.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

10.  Turning point in myocarditis.

Authors:  Madeleine W Cunningham
Journal:  Circ Res       Date:  2009-08-28       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.